Keyphrases
Pancreatic Cancer
100%
Pancreatic Ductal Adenocarcinoma
76%
Melanoma Cells
71%
Melanoma
63%
BRCA mutation Carriers
47%
Advanced Solid Tumors
47%
Germline BRCA mutation
47%
Pembrolizumab
47%
Cancer Patients
47%
Combination Therapy
46%
Breast Cancer Susceptibility Gene 1 (BRCA1)
39%
Tumor
36%
Clinically Significant
33%
Germ Cells
30%
BRCA2 mutation
30%
Tumor Progression
28%
Programmed Death-ligand 1 (PD-L1)
28%
Adipocyte
27%
Microenvironment
27%
MicroRNA
27%
Cancer Treatment
27%
BRCA mutation
26%
Median Overall Survival
26%
Overall Survival
25%
Transforming Growth Factor-β
25%
Lymphocyte Activation gene-3 (LAG-3)
25%
Germline BRCA
24%
Confidence Interval
23%
Previously Treated
23%
Chemotherapy
23%
Monotherapy
23%
BRCA1, BRCA2
23%
Olaparib
23%
First-in-human
23%
Cancer Cells
23%
Homologous Recombination Deficiency
23%
Metastasis
23%
Clinical Characteristics
23%
Survival Characteristics
23%
Metastatic Pancreatic Cancer
23%
Germline mutation
23%
Insulin-like Growth Factor 1 Receptor (IGF1R)
23%
Neoadjuvant
23%
Non-small Cell Lung Cancer (NSCLC)
23%
Health-related Quality of Life
23%
S100A4
23%
MTOR Inhibitor
23%
Global Disparities
23%
Negative Regulator
23%
Pancreas
23%
Medicine and Dentistry
Pancreas Cancer
100%
BRCA Mutation
71%
BRCA1
65%
Melanoma
63%
Melanoma Cell
57%
Pancreas Adenocarcinoma
56%
Germ Cell
47%
Malignant Neoplasm
47%
Personalized Medicine
47%
Microphthalmia Associated Transcription Factor
47%
Arm
40%
Keratinocyte
35%
Biological Marker
33%
Metastatic Carcinoma
32%
Overall Survival
29%
BRCA2
27%
microRNA
26%
Combination Therapy
25%
Ovarian Cancer
25%
Colorectal Carcinoma
25%
Lymphocyte Activation
25%
Olaparib
23%
Germline Mutation
23%
Quality of Life
23%
Tumor Progression
23%
Primary Tumor
23%
Genetic Screening
23%
Ascites
23%
Pembrolizumab
23%
Solid Malignant Neoplasm
23%
Systematic Review
23%
Preoperative Treatment
23%
Sex Hormone
23%
Notch Signaling
23%
Adipocyte
23%
Meta-Analysis
23%
Cell Culture
23%
Racial Disparity
23%
Receptor Antibody
23%
Doxorubicin
23%
Ridaforolimus
23%
Dalotuzumab
23%
Gastroesophageal Junction
23%
Gonad
23%
Syndecan 1
23%
Fibrinogen
23%
Protein P53
23%
Protein Kinase B
23%
Adjuvant
23%
Molecular Profiling
23%